Kamis, 04 Juni 2026 - 07:11 WIB

Find and Follow Us

Global Markets

IHSG 5,941.07 -4.11%

S&P 500 7,553.68 -0.74%

NASDAQ 26,853.98 -0.89%

Dow Jones 50,687.07 -1.21%

FTSE 100 10,332.30 -0.40%

CAC 40 8,150.42 -0.71%

Nikkei 225 68,402.13 +0.00%

Hang Seng 25,633.21 -1.56%

Shanghai 4,083.97 +0.22%

KOSPI 8,801.49 +0.00%

STI 5,138.24 +0.80%

ASX 200 8,785.70 +0.00%

Sensex 74,346.17 -0.41%

Gold 4,482.90 -0.14%

Silver 73.40 -2.54%

Oil (WTI) 95.44 +1.79%

Brent 97.24 +1.29%

Copper 6.49 -2.38%

Gas Alam 3.24 +2.31%

Bitcoin 64,223.26 +0.00%

Ethereum 1,813.58 +0.00%

USD/IDR 17,926.00 +0.38%

EUR/USD 1.16 -0.11%

Advertisement

HerLens resmi menutup rangkaian program BrightHer 2025 dalam upaya eliminasi kanker serviks di Indonesia.

BrightHer 2025: HerLens Dorong Akselerasi Skrining Kanker Serviks Lewat Teknologi AI di Indonesia

Redaksi • 12 Desember 2025

Latest Updates

- Advertisement -

HerLens resmi menutup rangkaian program BrightHer 2025 dalam upaya eliminasi kanker serviks di Indonesia.

14:30 WIB • 12 Desember 2025

BrightHer 2025: HerLens Dorong Akselerasi Skrining Kanker Serviks Lewat Teknologi AI di Indonesia

HerLens melalui BrightHer 2025 mempercepat akses skrining kanker serviks di Indonesia dengan teknologi AI, pelatihan tenaga…